SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-377104
Filing Date
2015-11-13
Accepted
2015-11-13 16:24:38
Documents
9
Period of Report
2015-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d57558d6k.htm 6-K 11106
2 EX-99.1 d57558dex991.htm EX-99.1 304913
3 EX-99.2 d57558dex992.htm EX-99.2 182282
4 EX-99.3 d57558dex993.htm EX-99.3 9631
5 EX-99.4 d57558dex994.htm EX-99.4 9526
6 GRAPHIC g57558img1.jpg GRAPHIC 4735
7 GRAPHIC g57558img2.jpg GRAPHIC 6970
8 GRAPHIC g57558whitetext1.jpg GRAPHIC 119047
9 GRAPHIC g57558whitetext2.jpg GRAPHIC 114561
  Complete submission text file 0001193125-15-377104.txt   856846
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 151229452
SIC: 2834 Pharmaceutical Preparations